A new class of drugs called PARP inhibitors has successfully slowed the spread of ovarian cancer for some patients, but the treatments are less effective for many others.
A new class of drugs called PARP inhibitors has successfully slowed the spread of ovarian cancer for some patients, but the treatments are less effective for many others.